665 Views
IRB Operations Advanced Track
2019 AER Conference
Advanced
Christine DeLussey, MS, CIP
IRB Operations Supervisor, Children's Hospital of Philadelphia
Julie M. Eiserman, MA, CCRP
Senior Regulatory Analyst, National Institutes of Health
Caitlin Alcorn, MPA, CIP
Senior Research Compliance Administrator, University of Oregon
The revised Common Rule includes many changes to the categories of exemption including the introduction of new categories. The main implication of these changes is that some human subjects research that previously required expedited IRB review may now be considered exempt. The research oversight community is awaiting detailed guidance about how to interpret and apply these regulatory changes. This session will evaluate determinations of exemption under the revised Common Rule at different institutions. Using real case examples, this session will delineate how organizational requirements, along with the special considerations of exempt reviewers, may factor into exempt determinations. Before attending this session, attendees should be familiar with the revised Common Rule exempt categories. During this session, speakers and attendees will: